A Two-Year Observational Study to Evaluate Conversion Rates from High- and Low-Risk Patients with Amnestic Mild Cognitive Impairment to Probable Alzheimer's Disease in a Real-World Setting
- 문서 유형
- 연구출판물 · 학술지 논문
- 등재
- ESCIScopus
- 저널 순위
- JCR Q2Scopus Q2
- 저널
- JOURNAL OF ALZHEIMERS DISEASE REPORTS8(1) · pp.851 · 2024
- 피인용
- Scopus 6
- FWCI (Scopus)
- 0.94
- JCR IF
- JCR 2023 2.8
- ISSN
- 2542-4823
저자
- Jang, Hyemin제1저자Department of Neurology, Seoul National University Hospital, Seoul National University College of Medicine, Seoul, Republic of Korea
- Na, Duk L.Department of Neurology, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea
- Kwon, Jay CheolDepartment of Neurology, Changwon Fatima Hospital, Changwon, Republic of Korea
- 정나연Department of Neurology, Pusan National University Yangsan Hospital, Pusan National University School of Medicine, Yangsan, Republic of Korea
- Moon, YeonsilDepartment of Neurology, Konkuk University Medical Center, Konkuk University School of Medicine, Seoul, Republic of Korea
- Lee, Jung SeokDepartment of Neurology, Jeju National University College of Medicine, Jeju, Republic of Korea
- Park, Kyung-WonDepartment of Neurology, Cognitive Disorders and Dementia Center, Dong-A University College of Medicine and Institute of Convergence Bio-Health, Busan, Republic of Korea
- Lee, Ae YoungDepartment of Neurology, Chungnam National University School of Medicine, Daejeon, Republic of Korea
- Cho, HannaDepartment of Neurology, Gangnam Severance Hospital, Yonsei University College of Medicine, Seoul, Republic of Korea
- Lee, Jae-HongDepartment of Neurology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea
- Kim, Byeong C.Department of Neurology, Chonnam National University Medical School Hospital, Gwangju, Republic of Korea
- Park, Kee HyungDepartment of Neurology, College of Medicine, Gachon University Gil Hospital, Incheon, Republic of Korea
- Lee, Byung-ChulDepartment of Neurology, College of Medicine, Hallym University, Seoul, Republic of Korea
- Choi, HojinDepartment of Neurology, Hanyang University Guri Hospital, Guri, Republic of Korea
- Kim, JieunDepartment of Medical, Eisai Korea Inc., Seoul, Republic of Korea
- Park, Mee Young교신저자Department of Neurology, Yeungnam University College of Medicine, Daegu, Republic of Korea
초록
Background: Predicting conversion to probable Alzheimers disease (AD) from amnestic mild cognitive impairment (aMCI) is difficult but important. A nomogram was developed previously for determining the risk of 3-year probable AD conversion in aMCI. Objective: To compare the probable AD conversion rates with cognitive and neurodegenerative changes for 2 years from high- and low risk aMCI groups classified using the nomogram. Methods: This prospective, multicenter, observational study was conducted in Korea. A total of patients were classified as high- or low-risk aMCI according to the nomogram and followed-up for 2 years to compare the annual conversion rate to probable AD and brain structure changes between the two groups. Results: In total, 176 (high-risk, 85; low-risk, 91) and 160 (high-risk, 77; low-risk, 83) patients completed the 1-year and 2-year follow-up, respectively. The probable AD conversion rate was significantly higher in the high-risk (Year 1, 28.9%; Year 2, 46.1%) versus low-risk group (Year 1, 0.0%; Year 2, 4.9%, both p < 0.0001). Mean changes from baseline in Seoul Neuropsychological Screening Battery-Dementia Version, Clinical Dementia Rating-Sum of Box, and Korean version of the Instrumental Activities of Daily Living scores and cortical atrophy index at Years 1 and 2 were significantly greater in the high-risk group (p < 0.0001). Conclusions: The high-risk aMCI group, as determined by the nomogram, had a higher conversion rate to probable AD and faster cognitive decline and neurodegeneration change than the low-risk group. These real-world results have clinical implications that help clinicians in accurately predicting patient outcomes and facilitating early decision-making. Trial Registration: ClinicalTrials.gov (NCT03448445)
키워드
Alzheimer's diseaseamnestic mild cognitive impairmentconversion rateneurodegenerationneuropsychometrynomogram
식별자
- Scopus EID
- 2-s2.0-85193747302



로그인
연구물 목록으로